Biopsy-Proven Minimal Change Disease in a Patient with Primary Biliary Cholangitis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0734; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Given the patient's worsening renal function and persistent anasarca, patient was started on prednisone 60 mg with tapering regimen, diuretic, ACEI, and a low-sodium diet were prescribed. For patients with contraindications to steroids or frequent relapses, alternative immunosuppressants such as cyclophosphamide, calcineurin inhibitors, mycophenolate-mofetil, and rituximab can be considered. Figure 1: Electron Microscopy 4800x; extensive foot process effacement consistent with minimal change nephropathy."
Biopsy • Clinical • Glomerulonephritis • Hepatology • Immunology • Nephrology • Primary Biliary Cholangitis • Renal Disease
|
|
Heidi Duong; Bahman John Moghadam; Neeraj Sharma
|